Isocaine HCL en es it fr

Isocaine HCL Brand names, Isocaine HCL Analogs

Isocaine HCL Brand Names Mixture

  • No information avaliable

Isocaine HCL Chemical_Formula


Isocaine HCL RX_link

Isocaine HCL fda sheet

Isocaine_HCL FDA

Isocaine HCL msds (material safety sheet)

Isocaine_HCL MSDS

Isocaine HCL Synthesis Reference

No information avaliable

Isocaine HCL Molecular Weight

129.164 g/mol

Isocaine HCL Melting Point

223-226 oC

Isocaine HCL H2O Solubility

Freely soluble as HCl salt

Isocaine HCL State


Isocaine HCL LogP


Isocaine HCL Dosage Forms

Extended release tablet (500 mg or 1000 mg)

Isocaine HCL Indication

For use as an adjunct to diet and exercise to improve glycemic control in adult patients (18 years and older) with type 2 diabetes.

Isocaine HCL Pharmacology

Metformin is an antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and daylong plasma insulin response may actually decrease.

Isocaine HCL Absorption

Absorbed over 6 hours, bioavailability is 50 to 60% under fasting conditions. Food delays absorption.

Isocaine HCL side effects and Toxicity

Acute oral toxicity (LD50): 350 mg/kg [Rabbit]. It would be expected that adverse reactions of a more intense character including epigastric discomfort, nausea, and vomiting followed by diarrhea, drowsiness, weakness, dizziness, malaise and headache might be seen.

Isocaine HCL Patient Information

Isocaine HCL Organisms Affected

Humans and other mammals